Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab

NCT03804554 ·Status: COMPLETED

A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)

NCT00290550 ·Status: TERMINATED ·Phase: PHASE2

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

NCT02193152 ·Status: TERMINATED ·Phase: PHASE2

Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients

NCT04923945 ·Status: COMPLETED ·Phase: PHASE3

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

NCT05933044 ·Status: COMPLETED

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

NCT01000025 ·Status: COMPLETED ·Phase: PHASE3

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

NCT01721759 ·Status: COMPLETED ·Phase: PHASE2

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

NCT00003869 ·Status: COMPLETED ·Phase: PHASE3

Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer

NCT00005059 ·Status: COMPLETED ·Phase: PHASE2

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

NCT01595074 ·Status: NOT_YET_RECRUITING

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

NCT00020202 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

NCT02590965 ·Status: COMPLETED ·Phase: PHASE2

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

NCT00818441 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs

NCT02350764 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

NCT04253964 ·Status: RECRUITING ·Phase: PHASE2

Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients

NCT03453307 ·Status: UNKNOWN

MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

NCT00174369 ·Status: TERMINATED ·Phase: PHASE2

A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status

NCT07034391 ·Status: RECRUITING ·Phase: PHASE2

Examining Clinical Trial Participation for Small Cell Lung Cancer Patients

NCT05769504 ·Status: NOT_YET_RECRUITING

Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer

NCT07328945 ·Status: RECRUITING

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

NCT02009605 ·Status: UNKNOWN ·Phase: PHASE2

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

NCT02949843 ·Status: TERMINATED ·Phase: PHASE2

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

NCT04807114 ·Status: RECRUITING

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

NCT06840782 ·Status: RECRUITING ·Phase: PHASE3

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00040794 ·Status: COMPLETED ·Phase: PHASE2